Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:drug |
| gptkbp:ATCCode |
L02BA52
|
| gptkbp:CASNumber |
gptkb:10540-29-1
|
| gptkbp:chemicalFormula |
C25H27NO2
|
| gptkbp:drugClass |
selective estrogen receptor modulator
|
| gptkbp:hasSMILES |
CC/C(=C(/C1=CC=C(C=C1)O)C2=CC=CC=C2)/C3=CC=C(C=C3)O
|
| gptkbp:hasTherapeuticUse |
gptkb:cancer
|
| gptkbp:hasUNII |
6QX8J75Z5B
|
| https://www.w3.org/2000/01/rdf-schema#label |
endoxifen
|
| gptkbp:isActiveMetaboliteOf |
gptkb:tamoxifen
|
| gptkbp:IUPACName |
(Z)-4-[1-(4-hydroxyphenyl)-2-phenylbut-1-enyl]phenol
|
| gptkbp:legalStatus |
investigational
|
| gptkbp:metabolism |
gptkb:tamoxifen
|
| gptkbp:molecularWeight |
373.49 g/mol
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL2103837
3083548 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
gptkb:(Z)-endoxifen
gptkb:4-hydroxy-N-desmethyltamoxifen gptkb:Z-endoxifen |
| gptkbp:bfsParent |
gptkb:tamoxifen
|
| gptkbp:bfsLayer |
6
|